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Abstract
Background: Outcomes after peripheral nerve injuries are poor despite current nerve repair techniques. Currently, there is no
conclusive evidence that mammalian axons are capable of spontaneous fusion after transection. Notably, certain invertebrate
species are able to auto-fuse after transection. Although mammalian axonal auto-fusion has not been observed experimentally,
no mammalian study to date has demonstrated regenerating axolemmal membranes contacting intact distal segment axolemmal
membranes to determine whether mammalian peripheral nerve axons have the intrinsic mechanisms necessary to auto-fuse after
transection.
Objective: This study aims to assess fusion competence between regenerating axons and intact distal segment axons by enhancing
axon regeneration, delaying Wallerian degeneration, limiting the immune response, and preventing myelin obstruction.
Methods: This study will use a rat sciatic nerve model to evaluate the effects of a novel peripheral nerve repair protocol on
behavioral, electrophysiologic, and morphologic parameters. This protocol consists of a variety of preoperative, intraoperative,
and postoperative interventions. Fusion will be assessed with electrophysiological conduction of action potentials across the
repaired transection site. Axon-axon contact will be assessed with transmission electron microscopy. Behavioral recovery will
be analyzed with the sciatic functional index. A total of 36 rats will be used for this study. The experimental group will use 24
rats and the negative control group will use 12 rats. For both the experimental and negative control groups, there will be both a
behavior group and another group that will undergo electrophysiological and morphological analysis. The primary end point will
be the presence or absence of action potentials across the lesion site. Secondary end points will include behavioral recovery with
the sciatic functional index and morphological analysis of axon-axon contact between regenerating axons and intact distal segment
axons.
Results: The author is in the process of grant funding and institutional review board approval as of March 2020. The final
follow-up will be completed by December 2021.
Conclusions: In this study, the efficacy of the proposed novel peripheral nerve repair protocol will be evaluated using behavioral
and electrophysiologic parameters. The author believes this study will provide information regarding whether spontaneous axon
fusion is possible in mammals under the proper conditions. This information could potentially be translated to clinical trials if
successful to improve outcomes after peripheral nerve injury.
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Introduction
Background
Peripheral nerve injuries (PNIs) are devastating and life-altering
events that affect 20 million Americans per year and result in
an annual economic cost of $150 billion [1]. Despite current
nerve repair techniques, recovery from PNIs is often prolonged,
incomplete, and associated with poor functional outcomes [2].
After primary repair of a peripheral nerve laceration,
regenerating axons frequently contact distal nerve segments
that have undergone Wallerian degeneration (WD). WD
establishes the environment necessary for axon regeneration.
Axons regenerate within Schwann cell tubes at approximately
1 mm per day to reach sensory or motor end organs [3].
In certain invertebrate species, WD does not occur for weeks
to months after an axon is severed. The regenerating axons
frequently make contact with intact distal segment axons and
auto-fuse, which restores axon continuity between proximal
and distal segments and enables recovery of nerve function
within days [4-6]. Auto-fusion occurs with high specificity, as
existing evidence suggests that regenerating axons can recognize
and fuse with their original distal ends. The mechanisms
underlying this specificity are still being investigated, but it is
believed that there is overlap with the molecular players
involved in auto-fusion. It is critical to note that
membrane-bound receptors on the regenerating axolemmal
membranes contact their respective ligands bound to
phosphatidylserine on the axolemmal membranes of the distal
segment axons. Therefore, axolemmal-axolemmal contact is
required for fusion to occur [5].
There are numerous differences between the nerve structure of
mammals and invertebrates. Many invertebrates have single
axons that innervate a distal target, whereas mammals have
nerves with highly organized motor and sensory fascicles
containing many axons [3,7]. Peripheral nerves in mammals
have complicated architecture consisting of multiple
compartmentalized layers. Axons are compartmentalized into
fascicles, which can be motor, sensory, or mixed fascicles.
Mammalian peripheral nerve axons are encased by Schwann
cells and produce myelin sheaths in myelinated nerves. In the
nematode Caenorhabditis elegans, mechanosensory axons are
surrounded by glial cells that do not produce myelin [8].
The most notable difference between mammalian and
invertebrate species is the time for WD in the distal segment to
occur. In mammals, regenerating axons contact distal segment
axons that have undergone WD because of the time delay for
regenerating axons to outgrow and reach the distal segment.
This alone prevents axon auto-fusion in mammals, even if they
do possess the intrinsic machinery necessary for fusion. Because
of the delayed WD and presence of molecular fusion
mechanisms observed in invertebrates, regenerating axons
contact intact distal axons, which leads to auto-fusion [5,9].
Notably, in C elegans, reduced retraction of the severed axon
ends, reduced degeneration of the distal segment, and an
increased number of regenerating axons from the proximal
segment strongly correlate with the success of axonal
auto-fusion. These factors facilitate fusion by providing a
reduction in the distance between the proximal and distal ends
of the axon, maintaining an intact distal segment, and providing
a greater probability of contact between the two segments [9].
In contrast to the heavily myelinated axons produced by
Schwann cells in the mammalian peripheral nervous system,
invertebrate axons are surrounded by glia that either do not
produce myelin, such as in C elegans [8], crayfish [10], and
leeches [11], or produce a thin layer of myelin, like earthworms
[12]. This begs the question as to whether the presence of
heavily myelinated axons could be one factor potentially
inhibiting axon auto-fusion in mammals, as myelin is a known
inhibitor of nerve regeneration [13].
Additionally, invertebrates such as C elegans do not have
injury-induced immune responses that are present in mammals
[6]. Overall, the immune response to PNI in mammals is
conducive to successful nerve regeneration [3]. However, in
terms of axon auto-fusion seen in certain invertebrates, the
immune response is detrimental because WD must be prevented
for auto-fusion to occur.
To date, there is no evidence of spontaneous axonal fusion in
mammalian axons after transection. Notably, mammalian axonal
fusion can be induced after transection by polyethylene glycol
(PEG) fusion techniques [4,14]. PEG fusion has been shown to
restore axon continuity and prevent WD. PEG fusion works by
removing water molecules between two opposing plasmalemmal
membranes, which allows the opposing membranes to contact
and fuse [15]. However, PEG fusion techniques do not lead to
rapid restoration of preinjury function, which can partly be
explained by the nonspecific random fusion of axons with mixed
motor and sensory end-organ targets [14]. Although there is no
evidence of mammalian auto-fusion, no mammalian study has
demonstrated axolemmal-axolemmal contact between
regenerating peripheral nerve axons and intact distal axons. No
study, to our knowledge, has simultaneously attempted to
enhance axon regeneration, prevent WD, prevent myelin
obstruction, and limit the immune response to establish contact
between regenerating axons and intact distal segment axons to
assess fusion competence. This is the aim of our novel nerve
repair protocol. It is hypothesized that these conditions can be
established in a rat model using a combination of
pharmacological and surgical interventions aimed to (1) prevent
Wallerian degeneration, (2) enhance axon regeneration, (3),
prevent myelin obstruction, (4) limit the injury-induced immune
response, and (5) establish contact between severed nerve ends.
Prevent Wallerian Degeneration
Numerous interventions have demonstrated the ability to delay
WD in mammals when implemented prior to nerve injury or
within a 4- to 6-hour critical window after the time of injury
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[16]. These interventions include cryotherapy and the
administration of ascorbic acid (vitamin C) [6,7,16-19].
Cryotherapy is also neuroprotective, as demonstrated by multiple
studies. Within the nervous system, cryotherapy decreases
oxygen demand and preserves energy stores. The net effect of
cryotherapy after PNI is delayed WD, reduced membrane
disruption, and decreased oxidative stress [20,21].
Marzullo et al [22] showed that rat sciatic nerves maintained
electrical conduction in vitro for up to 7 days with cooling to
6-9 °C versus 36 hours at 37-38 °C. Sea et al [23] demonstrated
a linear relationship between lower temperatures and delayed
WD on rat models. Cooling transected nerves to 13 °C, 23 °C,
and 32 °C delayed axon fragmentation up to 10, 6, and 3 days,
respectively [23].
Ascorbic acid is an antioxidant that has demonstrated
neuroprotective effects. Calixto et al [24] demonstrated that oral
administration of ascorbic acid delayed WD up to 7 days versus
3 days in wild-type mice in a sciatic nerve transection model.
In this study, ascorbic acid was given in drinking water for 10
days before nerve injury. Immunofluorescence and electron
microscopy were used to confirm its protective effects on axon
degeneration.
Enhance Axon Regeneration
In order to establish contact between proximal and distal axons
before WD in the distal segment, regenerating axons must sprout
and advance in a timely manner. The probability of axon fusion
increases with a higher number of regenerating axons [9].
The L-type voltage-gated calcium channel antagonist nimodipine
has demonstrated efficacy in nerve regeneration in clinical
studies. After unilateral recurrent laryngeal nerve (RLN)
transection in 19 patients, vocal cord motion recovered 3 times
faster compared with historical controls when the RLN was
repaired with adjuvant nimodipine administration [25].
Additionally, a pilot study of nimodipine treatment in patients
with facial nerve paresis following maxillofacial surgery showed
earlier recovery and improved facial nerve function assessed
by the House-Brackmann scale after nimodipine treatment. In
this study, regeneration times described in the literature were
2 or 3 times longer compared with nimodipine treatment [26].
Cyanocobalamin (vitamin B12) is known to aid in the prevention
of neuronal breakdown [27]. Vitamin B12 plays a role in various
cellular processes that allow for preservation of neuronal
function [27,28]. It also has the ability to promote regeneration
and improve the function of damaged sciatic nerves by
upregulating brain-derived neurotrophic factor expression at
the mRNA and protein levels [29]. Additionally, Okada et al
[30] demonstrated that high-dose vitamin B12 improves nerve
function after PNI [30,31].
Prevent Myelin Obstruction
For many years, it has been recognized that myelin sheaths and
myelin debris are present at the site of nerve transection [32,33].
More specifically, observations with electron microscopy have
made it apparent that transected axonal ends are capped by
collapsed myelin sheaths [34,35].
Lysophosphatidylcholine (LPC), an endogenous
lysophospholipid, has been used to induce demyelination in
order to study methods to enhance or promote remyelination
[36-38]. LPC is commonly injected locally within myelin
sheaths to induce rapid demyelination within 30 minutes [39].
Epineural injection leads to localized demyelination. From a
morphological standpoint, there is no clear damage to
surrounding Schwann cells or axons, which also makes it an
ideal molecule to study demyelination [39].
Limit the Injury-Induced Immune Response
Corticosteroid treatment has been shown to inhibit the
inflammatory response and reduce the recruitment of
macrophages. Steroids such as dexamethasone act by inhibition
of phospholipase A2, a critical enzyme in the production of
inflammatory cytokines [40]. Additionally, steroids are believed
to inhibit lipid peroxidation after PNI and consequently enhance
recovery [41].
Dexamethasone has anti-inflammatory effects and has been
shown to enhance axon regeneration and functional recovery
after PNI in multiple studies [29,42,43]. Using a rat sciatic nerve
model, Mohammadi et al [43] demonstrated that topical
application of dexamethasone to transected nerve ends placed
within a silicone tube resulted in enhanced functional recovery.
In another study by Sun et al [29] using a rat sciatic nerve injury
model, simultaneous administration of dexamethasone and
vitamin B12 enhanced axon regeneration of myelinated nerve
fibers and improved sciatic functional index (SFI) scores and
sensory nerve conduction velocity [29].
Establish Contact Between Severed Nerve Ends
Severed nerve ends must be in proximity for contact between
regenerating axons and distal segment axons to occur. This will
be performed with microsuture repair with a silicone tube. The
proximal and distal transected nerve ends will be inserted into
the silicone tube and secured to the tube with microsuture (eg,
10-0 nylon) to guide regenerating axons to the distally transected
nerve end. The epineuria of the proximal and distal ends will
be sutured directly to the ends of the silicone tube.
Silicone is nonabsorbable and impermeable to large molecules,
which is ideal for controlling and manipulating the local
microenvironment [7,44]. This controlled microenvironment
has been useful to study the effects of growth factors on nerve
regeneration by adding various growth factors within the tube
between the transected nerve ends. For the purposes of this
study, the silicone tube will surround and protect the transected
nerve ends to establish a calcium-free microenvironment and
minimize calcium-induced neurotoxicity.
Altogether, these medications and interventions will be used in
order to prevent WD, enhance axon regeneration, prevent myelin
obstruction, and limit the immune response (Table 1).
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Experimental Goals and Design
The goal of this experiment is to determine if spontaneous axon
fusion occurs under the proper conditions. The proposed novel
nerve repair protocol will aim to promote axolemmal-axolemmal
contact between regenerating axons and intact distal segment
axons. Preoperative interventions include administration of
multiple medications, such as nimodipine, cyanocobalamin,
ascorbic acid, and dexamethasone, which have all been shown
to delay WD or enhance axon regeneration. Intraoperative
interventions include hypotonic calcium-free saline, ethylene
glycol tetraacetic acid (EGTA), and application of a silicone
tube to establish a favorable calcium-free microenvironment to
delay WD and prevent formation of reactive oxygen species.
In addition, LPC will be injected into the distal severed nerve
end to dissolve the myelin sheaths that prevent
axolemmal-axolemmal contact. Postoperatively, the drug
cocktail will be continued until the end of the experiment at 42
days to allow for adequate time for regenerating axons to contact
the distal segment axons. Further, cryotherapy in the form of
ice packs will be applied immediately postoperatively and
continued for 42 days to delay WD and increase the likelihood
of axolemmal-axolemmal contact. This study will be concluded
at 42 days based on previous studies that demonstrated a plateau
of SFI recovery after peripheral nerve repairs [14].
Study End Points and Modalities
Three study end points will be assessed. The primary objective
will be to determine whether axon auto-fusion occurred. This
will be analyzed by the electrophysiological conduction of
compound action potentials (CAP) and compound muscle action
potentials (CMAP). As a secondary end point, this study will
assess whether axolemmal-axolemmal contact was achieved by
viewing transmission electron microscopy (TEM) cross sections
and sagittal sections of the distal segments of axons at different
time points. Another secondary end point is the assessment of
functional recovery using the SFI. SFI is a standardized gait
analysis protocol frequently used to assess functional outcomes
after sciatic nerve injury [14,45,46].
Study Groups and Sample Sizes
This experiment will require the use of 36 rats. The negative
control group will consist of 12 rats that will undergo sciatic
nerve transection and standard microsurgical nerve repair with
microsutures. The experimental group will be 24 rats that will
undergo standard microsurgical nerve repair of a severed sciatic
nerve with the addition of the preoperative, intraoperative, and
postoperative interventions outlined in the novel nerve repair
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protocol. For the experimental group, 4 rats will be assigned to
the behavior group for analysis and will undergo SFI testing
preoperatively and postoperatively. For the negative control
group, 2 rats will be assigned to the behavior group for analysis
and will undergo SFI testing preoperatively and postoperatively.
This makes for a total of 6 rats needed for behavioral analysis.
For the experimental group, 4 rats will be assigned to
electrophysiologic and morphologic analysis at each time point
by re-exploring nerve repair sites on postoperative day (POD)
3, 7, 14, 21, and 42, for a total of 20 rats. The negative control
group will be set up correspondingly for the electrophysiologic
and morphologic analysis groups, except half as many rats will
be used. This makes for a total of 10 rats needed for the negative
control group and 20 rats needed for the experimental group.
For the negative controls, more than one rat for each group will
be used in case there are any unexpected issues that arise in one
rat.
This study will not have a true control group consisting of
unoperated rats. This is because this is a pilot study and axon
regeneration after sciatic nerve transection has been thoroughly
studied. The negative controls and experimental groups will be
compared with unoperated animals in studies performed by
Mikesh et al [14] and Ghergherehchi et al [45].
Rats in the negative control group will have their sciatic nerves
transected and repaired with microsutures. None of the other
interventions described in our protocol will be used for the
negative control group. The reason for the negative control
group is to compare the results of microsuture repair, the current
gold standard repair in the absence of a nerve gap, with this
novel repair protocol. This study will assess the outcomes of
the proposed nerve repair protocol to the current gold standard
microsuture repair.
For both the negative control and experimental groups, there
will be two separate groups, the behavioral group and the
electrophysiology and morphological analysis group. The
behavioral groups will be studied using the SFI to determine
functional outcomes after the standard nerve repair or the novel
nerve repair protocol. The behavioral group will not be
euthanized until POD 42. The electrophysiology and
morphological analysis groups will be divided into 5 separate
groups (POD 3, 7, 14, 21, and 42). Each group will undergo
reoperation on their respective postoperative day from the initial
operation in order to perform electrophysiological testing. After
electrophysiology is performed, the entire sciatic nerve will be
harvested for morphological analysis. Once the sciatic nerve is
harvested, these rats will be euthanized. A schematic of the
protocol methods is summarized in Figure 1.
Figure 1. Experimental and negative control groups. The left flowchart represents the behavioral group breakdown and the right flowchart represents
the negative control group breakdown. In both experimental and negative control groups, there will be behavioral and electrophysiological/morphological
groups. In the electrophysiological/morphological groups, re-exploration and analysis will be performed on postoperative days 3, 7, 14, 21, and 42. SFI:
sciatic functional index.
Protocol
The first part of the protocol will involve preoperative
administration of medications, which will start 2 days before
the surgical intervention. These medications will continue 42
days after the operation until the conclusion of the study. For
the surgical protocol modified from Mikesh et al [14] and
Ghergherehchi et al [45], anesthesia will be induced with
intraperitoneal injection of ketamine (90 mg/kg) and xylazine
(10 mg/kg) [14,45]. The lateral aspect of the left hindlimb will
be trimmed and disinfected with 10% povidone-iodine. A 2- to
3-cm incision will be made above the thigh muscle in the left
hindlimb of each rat. The biceps femoris muscle will be split
in parallel to the muscle fibers with dissection scissors. The
sciatic nerve will be trimmed with microdissection scissors to
remove any connective tissue. The sciatic nerve will be
stimulated to confirm that it can conduct action potentials. The
exposed sciatic nerve will be bathed with sterile Plasma-Lyte
A (Baxter Healthcare Corp), a calcium-free hypotonic saline
solution to prophylactically reduce calcium-induced acute axon
degeneration (AAD) that occurs after cut severance. The
exposed nerve ends will be bathed in 5-mmol/L EGTA in
distilled water to prophylactically chelate extracellular calcium
and reduce AAD that occurs after cut severance. Noncrushing
double approximating Acland clamps will be applied to proximal
and distal ends of the sciatic nerve prior to cut severance to
prevent nerve retraction and mechanically create a complete
membrane seal to prevent calcium-induced neurotoxicity. Each
clamp will be applied 1 cm away from the transection site. Cut
severance will be performed by completely transecting the
sciatic nerve with a single stroke of dissection scissors to
completely sever all the peripheral nerve axons. LPC will be
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applied to the distal nerve end to dissolve the myelin sheath to
allow regenerating axons to contact distal segment axons. Using
a micromanipulator, the 1-μm tip of a micropipette will be
introduced into the fiber bundle beneath the epineurium and the
volume of solution contained within the tip will be injected
(about 0.0002 mL) by applying slight positive pressure to the
syringe plunger [39]. The silicone tube will be placed to protect
and align the severed proximal and distal nerve ends. The ends
of the nerves should be in contact within the silicone tube, and
10-0 nylon microsutures will be used to secure the silicone tube
to the nerve ends. When suturing the nerve to the silicone tube,
the needle will be inserted into the epineural sheath using
microneedle holders to avoid axonal damage. Multiple silicone
tubes will be available with the proper length and diameter to
fit the rat sciatic nerve. The double approximating clamps will
then be released. Throughout the procedure, the nerve ends will
be moistened with calcium-free solution and EGTA. Skin over
the lesion site will be closed with sutures and surgical staples.
The behaviorally studied rats will be given a 5 mg/kg
subcutaneous injection of ketoprofen after surgery. Immediately
after closure, continuous cryotherapy using ice packs will be
applied to the left leg distal to the transection site and secured
with surgical tape. A diagram of the protocol is demonstrated
in Figure 2.
For rats undergoing electrophysiologic and morphological
analysis, nerve repair sites will be re-explored on POD 3, 7, 14,
21, and 42. Electrophysiological tests will be performed first
to assess nerve continuity (see “Electrophysiological Testing”
section below). After electrophysiological recordings are
performed, the entire sciatic nerve will be removed. This will
be used for morphological analysis by electron microscopy (see
“Morphological Analyses of Sciatic Nerves” section below).
For the electrophysiologic and morphological analysis groups,
postoperative euthanasia will be performed for the POD 3, 7,
14, 21, and 42 experimental group animals after reoperation
and harvesting of the sciatic nerve (Textbox 1).
Figure 2. Novel nerve repair protocol. This image compares the usual course of nerve transection (on the left) with the theoretical benefits of the novel
nerve repair protocol if fusion occurs (on the right). In (b), note that calcium influx after transection leads to acute axon degeneration, which is noted
in (c). Also in (c), membrane seals begin to form (black circles). In (d), axon regeneration begins in the proximal segment. In (e), Wallerian degeneration
occurs and regenerating axons regenerate within Schwann cell tubes. In (f), the preoperative interventions have been administered and double approximating
clamps (gray vertical lines) are applied to the proximal and distal nerve ends, which will act to seal the axolemmal membranes and prevent further axon
degeneration. In (g), the silicone tube is sutured in place after nerve ends have been rinsed with calcium-free saline. If mammals possess the machinery
necessary for auto-fusion under the proper conditions, axon continuity could theoretically be restored with return of function, as represented by (h) and
(i).
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Textbox 1. Novel nerve repair protocol.
Preoperative interventions
• Administer nimodipine 6 mg/kg, gastric gavage once daily (then continue for 44 days)
• Administer cyanocobalamin 1 mg/kg, intraperitoneal injection once daily (then continue for 44 days)
• Administer ascorbic acid 2.5 mg, intraperitoneal injection once daily (then continue for 44 days)
• Administer dexamethasone 1 mg/kg, intraperitoneal injection once daily (then continue for 44 days)
Intraoperative interventions
• Expose sciatic nerve with standard microsurgical technique for primary nerve repair
• Confirm sciatic nerve can conduct action potentials by measuring the presence of compound action potentials and compound muscle action
potentials
• Bathe exposed nerve in hypotonic calcium-free saline
• Apply noncrushing double approximating Acland clamps to proximal and distal end prior to cut severance
• Apply lysophosphatidylcholine to the distal nerve end using a 1-μm micropipette tip
• Apply a silicone tube and reapproximate nerve ends with 10-0 nylon microsuture
• Release double approximating clips
• Close surgical site
Postoperative interventions
• Continue medications (started preoperatively) until postoperative day 42
• Start cryotherapy (10-20 C) and continue until postoperative day 42
• Rats will undergo electrophysiological and morphological analysis by re-exploring nerve repair site on postoperative day 3, 7, 14, 21, and 42
• Behavior analyses by sciatic functional index scores will be performed until postoperative day 42
Electrophysiological Testing
Electrophysiological testing will be performed during the initial
surgery before and immediately after transection.
Electrophysiological testing will be identical to the protocol
from Mikesh et al [14] and Ghergherehchi et al [45]. It will also
be performed on reoperation for the electrophysiological and
morphological analysis study groups on POD 3, 7, 14, 21, and
42 [14,45].
Morphological Analyses of Sciatic Nerves
The sciatic nerves will be removed from the electrophysiological
and morphological analysis groups on POD 3, 7, 14, 21, and
42 after electrophysiological testing. Morphological analysis
will be similar to the protocol from Mikesh et al [14] and
Ghergherehchi et al [45]. Nerve fiber diameter and composition
will be assessed in the experimental group and compared with
the control group. Additionally, qualitative slide analysis will
be performed to assess contact of regenerating axons with intact
distal axons using TEM.
Behavior Analyses
Functional recovery of the sciatic nerve in rats will be assessed
using SFI scores identical to the protocols from Mikesh et al
[14] and Ghergherehchi et al [45]. SFI testing will be conducted
by individuals blind to which procedure the rat has received.
Animals will first be tested 3 days after surgery, then at POD
7, 14, 21, 28, 35, and 42. A successful recovery is qualified as
a score of –59 or better at any time point.
Individual discrepancy can be minimized by using the behavioral
analysis protocols outlined by Ghergherehchi et al [45]. This
algorithm requires training the behaviorally tested animals for
at least one week prior to surgery in order to acclimate the rats
to the testing procedures. In practice, the left hindlimb will
always be referred to as the experimental (injured) limb. Both
hind paws will be dipped in blue (left) or red (right) ink. The
rat will then be placed on a wooden board (100 mm in width)
lined with white paper strips (100 mm in width) and permitted
to run back to their home cage. A trial attempt without any
stopping or hesitation during at least three consecutive footprints
of both the left and right hindlimb will be considered acceptable
as a preprocedure control for later comparison, and the paper
strip will be collected for measurements. The normal footprint
length, experimental footprint length, normal toe spread,
experimental toe spread, normal intermediary toe spread, and
experimental intermediary toe spread will be measured in
millimeters for all footprints [14,45]. These values will be
averaged among the 3 footprints for each limb. Each rat will
run 2 trials, and the average will be documented as the SFI score
for that rat for that day.
Cryotherapy
Immediately after surgical closure, continuous cryotherapy will
be applied with ice packs and surgical tape to the left hindlimb
distal to the transection site. Skin temperature will be monitored
every 6 hours with a digital thermometer. The target temperature
range will be between 10 and 20 °C. The ice packs will be
continued for 42 days in order to maintain the target skin
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temperatures. Skin checks will be performed daily to ensure
that there are no freeze burns to the skin. The ice will be crushed
and wrapped in plastic wrap in order to fit the operated leg.
Statistical Analysis
As outlined in Mikesh et al [14], Excel (Microsoft Corp) will
be used to calculate means, linear regressions, and t test
comparisons. A 2-tailed Student t test will be used to compare
mean SFI scores for each treatment group on a given
postoperative day. Two-way analyses of variance will be
performed to analyze means and standard errors of SFI scores
[14,45-47]. CAPs and CMAPs will be recorded as all or none
on a binary scale to assess restoration of axon continuity. TEM
will be used to demonstrate whether axolemmal-axolemmal
contact has been established and will also be recorded as a
binary “yes” or “no.”
Data Monitoring
Dedicated staff will collect and monitor data according to the
study protocol and scheduled assessments. Data queries will be
addressed as needed.
Results
The author is currently in the process of obtaining institutional
review board approval. After setup, the study period will take
44 days to complete. The projected completion date, including
data analysis and manuscript writing, is December 2021.
Discussion
Contribution to the Literature
The use of PEG fusion has demonstrated that restoring axon
continuity and preventing WD alone is not sufficient to regain
preinjury function after PNI. This is likely due to the nonspecific
fusion of axons that occurs with PEG fusion [4,14]. This begs
the question as to whether fusion with high specificity would
theoretically restore preinjury function after PNI. More studies
will be needed to determine if this is the case. In our study, if
fusion does occur, this would reveal that mammals do possess
the molecular machinery necessary for auto-fusion and that this
mechanism is only expressed under the proper conditions. If
auto-fusion is possible, further experiments could be developed
to address questions regarding specificity and whether there is
mechanistic overlap with fusion, as is demonstrated by C
elegans. The author believes that these important outstanding
questions should be addressed experimentally before
determining that mammals do not express the machinery
necessary for auto-fusion, especially given the potential benefits
to patients that experience PNI. Additionally, if mammalian
peripheral axon auto-fusion occurs, further studies could assess
if these mechanisms are present in the central nervous system
and could be directed to improve outcomes after brain and spinal
cord injuries.
Potential Adverse Outcomes and Preventative
Measures
There is always a potential that the protocol could worsen axon
regeneration and functional outcomes compared with the
standard microsuture nerve repair. One factor that may impair
functional recovery is experimentally delaying WD. It is
important to note that although preventing WD is necessary for
auto-fusion, it is detrimental and inhibitory to axon regeneration.
Therefore, if fusion does not occur, axon regeneration may be
negatively impacted. This outcome will be monitored with SFI
testing in the negative control group, as described earlier.
Limitations
Because there are multiple mechanisms involved in axon
regeneration and WD, the author believes it is important to
provide multiple medications and interventions to address the
different pathways. This type of study design inherently
introduces confounding variables. However, the author believes
that addressing each mechanism simultaneously is essential to
providing the conditions necessary to achieve the goals outlined
by this protocol.
This study does not address nerve gaps. Nerve gaps are common
after PNI in humans, as separated nerve ends retract after
transection. These are often treated with nerve conduits,
allografts, or autografts [48]. This study focuses on sharp nerve
lacerations with minimal to no gap between nerve ends. Nerve
gaps will need to be addressed in additional future studies.
Data are lacking in higher mammals such as primates and
humans for the interventions outlined in this protocol, which is
another limitation of this study. The majority of research has
been performed on mice, rats, and a few invertebrate species,
such as C elegans.
Conclusion
Outcomes after peripheral nerve injuries and nerve repair are
poor. More research needs to be done to improve nerve repair
protocols. In this study, the efficacy of a proposed novel
peripheral nerve repair protocol will be evaluated using
behavioral and electrophysiological parameters. The author
believes this study will provide information regarding whether
spontaneous axon fusion is possible in mammals under the
proper conditions. If successful, this information could
potentially be translated to clinical trials to improve outcomes
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AAD: acute axon degeneration
CAP: compound action potential
CMAP: compound muscle action potential
EGTA: ethylene glycol tetraacetic acid
LPC: lysophosphatidylcholine
PEG: polyethylene glycol
PNI: peripheral nerve injury
POD: postoperative day
RLN: recurrent laryngeal nerve
SFI: sciatic functional index
TEM: transmission electron microscope
WD: Wallerian degeneration
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